about
Are herpes virus associated to aggressive periodontitis? A review of literatureImprovement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis.Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.The role of inflammation in lung cancer.Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review.Forensic miRNA: potential biomarker for body fluids?miRNAs: mediators of ErbB family targeted therapy resistance.Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.Dietary unsaturated fatty acids differently affect catecholamine handling by adrenal chromaffin cells.MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers.Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice.DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans.Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients.Correction: Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation.Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma.miRNAs as potential regulators of mTOR pathway in renal cell carcinoma.Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.The role of p73 G4C14-to-A4T14 polymorphism in the susceptibility to cervical cancer.Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794).Involving the microRNA Targetome in Esophageal-Cancer Development and BehaviorInfluence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) riskGenetic Polymorphism in EGF Is Associated with Prostate Cancer Aggressiveness and Progression-Free Interval in Androgen Blockade-Treated PatientsXPO5 genetic polymorphisms in cancer risk and prognosisGenital mycoplasmas and ureaplasmas in cervicovaginal self-collected samples of reproductive-age women: prevalence and risk factorsIL-6 polymorphism in non-small cell lung cancer: a prognostic value?Expression of microRNAs 16, 20a, 150 and 155 in anal squamous intraepithelial lesions from high-risk groupsTelomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the KidneyThe opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulationEverolimus resistance in clear cell renal cell carcinoma: miRNA-101 and HIF-2α as molecular triggers?
P50
Q26765338-EF5CDDC6-672D-47E8-A4C3-1799800FB20FQ34951665-734467C9-2A76-4520-A118-93A3E78BDBF1Q37968599-54BE8EF9-67BB-4A71-BA3A-55C2FF9A36CBQ37974776-7D6FEA74-BC74-4E6C-BC15-0B99BCEDAE1EQ38160090-46B2C6E1-5D22-42D6-8851-13B76601E486Q38206962-8889DBA2-9FBE-43F7-A2E3-E5082F965772Q38211072-51CE2BA0-CF69-4B96-9C7D-362736AC00EBQ38241429-04570FAE-DAE1-4C90-B4B5-C7E56E0D65E5Q38256477-401762E3-827B-4B65-818A-1D9C0A455087Q38881549-002EB548-3E72-478B-B2C4-B5C18DE35DD3Q39001625-B7FCCB9C-DDC3-4570-AFA1-5774EA922B39Q39034256-02B8148A-4EE9-4E76-B7B4-019088DE6649Q39349540-2A165DB4-CD2A-4292-A355-50E75317FA7DQ40213183-91CB67AB-7F22-40EE-93D2-569A0E39B8C4Q40288629-FE60112A-15D0-4E4B-9267-DA9ABECAD5D1Q40401994-232E1FC0-589F-4A9C-942E-D4D45707E3F2Q44178021-60BE5345-7930-4AAA-B90E-FD99B136B987Q45202446-948703C2-FA58-43C3-B18B-5153B7DE98C1Q45767168-36A7DB4B-FAE8-4188-B7F3-F2134C444E62Q46355053-1E9C0C94-1306-4E67-9285-EE86AE972C7FQ47359451-0729FA26-956A-4503-A587-5DB501570C35Q47553641-7D331AC4-5985-4674-B884-F0240F482452Q47674851-90D253D0-86B0-4701-A59D-8279CADA4D86Q51024623-6C77236E-694F-4F7B-B35B-6336F5B7C46CQ51854381-F2A39E4E-FBB4-46A1-AD74-CD7669E8A83BQ54310006-F5E4FBF8-E628-4221-B7C2-4D3EC8E21585Q54319536-4115E131-04C5-4F0D-A94E-D9A86D1EA17AQ57470577-573985C6-D6D6-4EDC-914C-116F6BFC5FB8Q58835456-1ADA6A2A-2AC9-4600-9117-820C106772D0Q58835498-00AA3180-5E9A-47FB-8745-F1A593B4C6E7Q61052626-53C922F8-D0C4-41CD-AA21-AFFF6256712FQ61052627-59F04062-DC37-4189-9B6F-1A16BF77B2DBQ61052631-2E653D15-877F-4795-BF0E-99B2A42D83DCQ61799084-DE4CF683-2CB3-4336-A66E-1148EE9259CFQ90410362-5A2D5264-D1EC-4322-B7D1-0F92797778E2Q91308339-53B4D4EC-FB04-42DE-8062-D539677AEBA7Q91571320-597250CB-E1E7-4B69-9391-33F8A1756545
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana Luisa Teixeira
@ast
Ana Luisa Teixeira
@en
Ana Luisa Teixeira
@es
type
label
Ana Luisa Teixeira
@ast
Ana Luisa Teixeira
@en
Ana Luisa Teixeira
@es
altLabel
Ana L Teixeira
@en
prefLabel
Ana Luisa Teixeira
@ast
Ana Luisa Teixeira
@en
Ana Luisa Teixeira
@es
P106
P21
P31
P496
0000-0002-7489-2211